Why Purity Testing Matters
In peptide research, purity isn’t a nice-to-have — it’s foundational to whether an experiment’s results can be trusted. An impure or misidentified compound can introduce confounding variables that undermine an entire study, especially in dose-response or mechanism-of-action research where precise compound identity is critical. Understanding how purity is tested — and what a Certificate of Analysis (COA) actually verifies — helps researchers evaluate suppliers and interpret documentation correctly.
High-Performance Liquid Chromatography (HPLC)
HPLC is the primary method used to determine peptide purity. In simple terms, it separates the components of a sample based on how they interact with a stationary phase inside a column, allowing analysts to measure what percentage of the sample is the target peptide versus other byproducts, truncated sequences, or degradation products.
A COA generated via HPLC typically reports a purity percentage — research-grade peptides are commonly expected to test above 98%. Anything significantly lower suggests a higher proportion of impurities that could interfere with experimental outcomes.
Mass Spectrometry (MS)
While HPLC measures how much of the target compound is present, mass spectrometry confirms what that compound actually is. MS measures the mass-to-charge ratio of ionized molecules, allowing analysts to confirm that a peptide’s molecular weight matches its expected structure. This step is critical for identity verification — it’s possible for a sample to show high purity via HPLC while still being the wrong compound entirely if MS confirmation is skipped.
What a Complete COA Should Include
A thorough Certificate of Analysis should show:
- Batch/lot number — for traceability to a specific production run
- HPLC purity percentage
- MS-confirmed molecular weight
- Testing date and, ideally, the testing lab or method used
- Storage recommendations specific to that compound
Some suppliers also provide amino acid analysis or additional stability data, though this is less universal.
Third-Party vs. In-House Testing
In-house testing is common and can be reliable, but third-party verification — testing conducted by an independent lab with no financial interest in the result — adds a layer of accountability that’s worth seeking out, particularly for compounds used in reproducibility-sensitive research.
Practical Takeaways for Researchers
- Always request a batch-specific COA, not a generic or outdated one
- Confirm both purity (HPLC) and identity (MS) are documented, not just one
- Be cautious of suppliers who can’t produce testing documentation on request
- Retain COAs alongside your lab records for each study, both for reproducibility and institutional documentation purposes
Purity documentation isn’t just a formality — it’s part of the scientific rigor that makes peptide research results meaningful and reproducible.